It not only allows them to share it with doctors and specialists anywhere, regardless of the payer network or EMR used, but also allows them to share it anonymously with scientists working to develop treatments and cures, providing Big Data to revolutionize treatment development and monetize via pharmaceutical companies, researchers and insurers.
Patients, doctors, and hospitals will put data into a compliant cloud which becomes part of the MediChain ecosystem and the blockchain stores pointers and rules on usage and anonymity, while the data itself is stored off-chain in the compliant cloud.Patients will be able to access their data at any time and allow other doctors and hospitals to access selected parts of the data, transcending individual electronic medical records systems.Researchers and Pharmaceutical companies will access the data as big data in fully anonymised form and use AI from our ML modules and our toolkit. It is monetized by the ability for patients to voluntarily give anonymised access to untampered data to pharmaceutical companies, researchers and insurers. Potentially it may also be used for prescription management.Its unique architecture allows fast access and small downloads to make it practical for everyday medical use.
The protocol is based on smart cards (optional), Homomorphic encrypted access rules tables, json data formats, lightweight and strong cryptography and blockchain technology, which brings enhanced transparency and reliability in medical data exchange at every level, from devices to EMR to unprecedented opportunities for privatised big data sharing.The protocol enables connections between patients, service providers, medical researchers and AIs located anywhere in the world, regardless of systems used so long as the systems can work with the almost universal and open json format.By improving patient data sharing and availability, and being open to add to any existing system or to be managed automatically by doctor or by patient, MediChain aims to allow better conditions for all parties, creating a better way of handling patient data than anything available today.By including different levels of access in rules MediChain seeks to neutralize the patient’s risk and increase their benefits.
